Le Lézard
Classified in: Health, Covid-19 virus
Subject: BFA

This Week in Health News: 11 Stories You Need to See


A roundup of the week's most newsworthy health industry press releases from PR Newswire, including updates on cannabis- and psilocybin-based treatments.

NEW YORK, Jan. 20, 2023 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help journalists covering the healthcare industry stay on top of the week's most newsworthy and popular releases, here's a roundup of stories from the week that shouldn't be missed.

The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that are available for download.

  1. New Survey Data Confirms Mental Health Remains Leading Challenge on College Campuses
    The survey confirms national reports that student mental health continues to decline. Furthermore, the survey also underscores campus leader concerns that institutions are not sufficiently prepared to offer students the necessary level of mental health support and resources.
  2. FDA Approves Luye Pharma's Rykindo® for the Treatment of Schizophrenia and Bipolar 1 Disorder
    The drug is administered via intramuscular injection once every two weeks and delivers the active ingredient, risperidone, via long-acting and extended-release microsphere technology.
  3. Biden Administration Extends COVID-19 Public Health Emergency Funding
    The Emergency Declaration extension will enable state governments to access remaining emergency funds to prevent transmission of COVID-19 and other infectious particles by upgrading HVAC systems, deploying air purification units, and making health-focused investments in infrastructure overall.
  4. Peloton Appoints Leslie Berland as Chief Marketing Officer
    Berland previously served as CMO at Twitter, where she oversaw marketing and communications, tasked with defining and deepening the brand's identity and influence globally. "Peloton is at a unique moment in its transformation journey, and I'm thrilled to be a part of it!" she said.
  5. Work & Mother partners with Nest Collaborative to provide virtual lactation consultations for working mothers
    The partnership between Work & Mother and Nest Collaborative will make it easier for parents to return to work after childbirth by providing them access to Nest Collaborative's International Board-Certified Lactation Consultants through the app associated with Work & Mother's office lactation suites.
  6. Ginkgo Bioworks and the Public Health Center of the Ukraine Ministry of Health Announce Collaboration to Implement Biosecurity Capabilities in Ukraine
    Through this partnership, Ginkgo is building upon the large-scale pathogen monitoring platform developed by its biosecurity and public health unit, Concentric by Ginkgo, to implement a nimble, on-the-ground biosecurity program for monitoring of biological threats found in critical wastewater systems.
  7. NHS reimburses the cost of cannabis treatment to the first Zereniatm Clinics UK patient
    This ground-breaking step validates Khiron's scientific and data-driven approach to demonstrate the efficacy, safety and cost-effectiveness of CBMPs on the management of chronic conditions such as pain and anxiety.
  8. NAMUH and Ginkgo Bioworks Announce Partnership to Produce Multiple Infant Nutrition Products
    Through this partnership, NAMUH will leverage Ginkgo's expertise in yeast strain engineering and fermentation process development to enable the production of various HMOs through yeast fermentation and work to unlock the possibility of making infant formula nutritionally robust and much closer to human breast milk.
  9. Apex Labs Granted Approval for 294 Patient Take Home Psilocybin Clinical Trial
    This randomized, double-blind, placebo-controlled phase 2b study will evaluate the efficacy, safety and tolerability of APEX-52 microdose, orally administered synthetic psilocybin drug product in treating depression and anxiety among adults diagnosed with Post-Traumatic Stress Disorder (PTSD).
  10. OncoK9 Liquid Biopsy Test Can Enhance Cancer Monitoring in Dogs, New Results Show
    Initially recommended for cancer screening and as an aid-in-diagnosis, OncoK9® ? The Liquid Biopsy Test for Dogstm is now also recommended for detection of residual disease and detection of recurrence in dogs previously diagnosed with cancer.
  11. WellSet Launches First Holistic Self-Care Benefit Backed by Insurance
    WellSet provides unlimited access to thousands of live and on-demand classes spanning 20+ evidence-based practices designed to improve mind, body, and emotional health, like Acupressure, Self-Hypnosis, and EFT/Tapping, in addition to Yoga, Mindfulness, and more.

Read more of the latest health-related releases from PR Newswire and stay caught up on the top press releases by following @PRNhealth on Twitter.

Helping Journalists Stay Up to Date on Industry News

These are just a few of the recent press releases that consumers and the media should know about. To be notified of releases relevant to their coverage area, journalists can set up a custom newsfeed with PR Newswire for Journalists.

Once they're signed up, reporters, bloggers and freelancers have access to the following free features:

About PR Newswire and PR Newswire for Journalists

For more than 65 years, PR Newswire has been the industry leader with the largest, most comprehensive distribution network of print, radio, magazine, television stations, financial portals and trade publications. PR Newswire has an unparalleled global reach of more than 200,000 publications and 10,000 websites and is available in more than 170 countries and 40 languages.

PR Newswire for Journalists (PRNJ) is an exclusive community that includes over 20,000 journalists, bloggers and influencers who are logging into their PRNJ accounts specifically looking for story ideas. PR Newswire thoroughly researches and vets this community to verify their identity as a member of the press, blogger or influencer. PRNJ users cover more than 200 beats and verticals.

For questions, contact the team at [email protected].

SOURCE PR Newswire


These press releases may also interest you

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...

3 jui 2024
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...

3 jui 2024
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

3 jui 2024
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: